06-Mar-2014 - Columbia Laboratories has reported strong annual results despite a fourth quarter affected by Actavis taking the manufacture of vaginal gel Crinone in-house and the “lumpiness” of Merck Serono.
05-Mar-2014 - Addiction doctors have petitioned the US FDA to prevent Zohydro ER, the first single-entity hydrocodone painkiller, hitting the market this month citing its potential for abuse. Its maker, Zogenix, has...
04-Mar-2014 - Cobra Biologics is looking for more scientists with plasmid production skills after BioCancell became the fifth firm in a year to ask the CMO to manufacture a DNA-based gene therapy...
04-Mar-2014 - Jubilant HollisterStier says the Warning Letter in place at its Montreal, Canada facility did not affect manufacturing or business as - twelve months later – the US FDA upgrades the...
26-Feb-2014 - Tokyo, Japan-based JCR Pharmaceuticals has asked UK firm Plasticell to help develop differentiation protocols for its range of candidate stem cell-based therapies.
26-Feb-2014 - DSM has reported modest growth in its pharma business as a shareholders advisory firm comes out in favour of the upcoming merger with Patheon.
26-Feb-2014 - As part of an effort to ease the transition between clinical and commercial launch for blister products, Almac has added new blistering technology at its US commercial packaging facility in Audubon,...
26-Feb-2014 - Cellceutix has selected Dr. Reddy’s Custom Pharmaceutical Services (CPS) for the formulation of its defensin mimetic drug Brilacidin for use in ophthalmic and otitis infections.
25-Feb-2014 - Ranbaxy has temporarily halted all shipments from two API plants currently under a US FDA consent decree, although both the firm and an analyst say a shortage is unlikely.
20-Feb-2014 - Four more drug excipient suppliers have been certified under the newly independent Excipact quality scheme.
20-Feb-2014 - Ben Venue Laboratories, a Boehringer Ingelheim subsidiary that was recently closed after a spate of quality problems, issued a US-wide voluntary recall for its Acetylcysteine Solution 10% at the patient level.
19-Feb-2014 - The European Commission (EC) has increased the pressure on Ireland, Italy, Poland and Slovenia to fall into line with other EU member States and introduce anti-drug counterfeiting legislation.
19-Feb-2014 - CMO Cytovance Biologics has entered into a manufacturing agreement with Pamlico Biopharma to develop a group of three human IgG monoclonal antibodies intended for the treatment of Streptococcus pneumoniae infections. ...
17-Feb-2014 - AMRI says it intends to expand its API business to target both generics and more complex molecules after reporting record full year revenue from contract services.
17-Feb-2014 - Sinopharm expects customer drug launches and its recent investment in cancer injectables to drive revenue gains and margin growth in 2014.
17-Feb-2014 - Recipharm has confirmed that it is making plans to go public this year, citing a desire to finance “rapid growth” and acqusitions as the motivation.
13-Feb-2014 - The US FDA has upgraded Hospira’s troubled Rocky Mount, North Carolina plant to VAI (voluntary action indicated) status though its 2010 Warning Letter still stands.
13-Feb-2014 - Catalent says it is adding 230 jobs at a Missouri plant recently earmarked for expansion.
12-Feb-2014 - Cobra says it will no longer need to rely on third-parties for its biologics quality control tests after receiving an extension to its GMP certification at a Swedish facility.
10-Feb-2014 - Perrigo Company has reported a 40% drop in contract manufacturing revenue year-on-year due to a key client, assumed by analysts to be J&J, returning to OTC in-house production.
06-Feb-2014 - Fine chemicals firm Johnson Matthey has asked the US to renew its license to make controlled substance drug APIs at its plant in Devens, Massachusetts
06-Feb-2014 - Recipharm says it has not decided whether to go public and list on the Swedish stock market after reports suggested it is preparing to join the exchange.
04-Feb-2014 - Johnson Matthey's decision to restructure its narcotic API business in light of increased UK competition has paid off, the company says.
03-Feb-2014 - Private antibiotics developer Melinta has established a team of “shadow” scientists who streamline research before outsourcing drug manufacture.
30-Jan-2014 - Increasing demand for HPAPIs has driven Patheon to invest in its Milton Park, UK manufacturing facility, the company says.